ANEBULO PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.00% for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-09.
Discontinued › Expense Statement
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2022-09-09
- ANEBULO PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2022 was 0.00%.
- ANEBULO PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2021 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 2 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|---|
| 2022-06-30 | 0.00% 10-K · filed 2022-09-09 | |
| 2021-06-30 | 0.00% 10-K · filed 2022-09-09 | |
| 2020-06-30 | 0.00% 10-K · filed 2021-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |